1. Home
  2. SID vs QURE Comparison

SID vs QURE Comparison

Compare SID & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Companhia Siderurgica Nacional S.A.

SID

Companhia Siderurgica Nacional S.A.

HOLD

Current Price

$1.86

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$23.15

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SID
QURE
Founded
1941
1998
Country
Brazil
Netherlands
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
1997
2007

Fundamental Metrics

Financial Performance
Metric
SID
QURE
Price
$1.86
$23.15
Analyst Decision
Strong Sell
Strong Buy
Analyst Count
1
12
Target Price
$1.40
$58.55
AVG Volume (30 Days)
3.0M
2.3M
Earning Date
11-04-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,522,708,358.00
$15,751,000.00
Revenue This Year
$4.93
N/A
Revenue Next Year
N/A
$153.45
P/E Ratio
N/A
N/A
Revenue Growth
4.02
N/A
52 Week Low
$1.24
$7.76
52 Week High
$1.88
$71.50

Technical Indicators

Market Signals
Indicator
SID
QURE
Relative Strength Index (RSI) 63.56 43.45
Support Level $1.60 $22.11
Resistance Level $1.88 $24.43
Average True Range (ATR) 0.06 1.41
MACD 0.02 0.46
Stochastic Oscillator 88.33 37.09

Price Performance

Historical Comparison
SID
QURE

About SID Companhia Siderurgica Nacional S.A.

Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations in railways and port terminals. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Share on Social Networks: